AVITA Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, AVITA Medical stock has a consensus rating of "Buy" and an average price target of $7.09. The average 1-year stock price forecast is 81.33% higher than the current stock price, while the lowest is $5.37 (+37.34%) and the highest is $9.99 (+155.50%).

Price Target: $7.09 (+81.33%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.37	$7.09	$5.92	$9.99
Change	+37.34%	+81.33%	+51.41%	+155.50%

* Price targets were last updated on May 15, 2026.

Analyst Ratings

The average analyst rating for AVITA Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	1	1	0	0	0	0
Total	6	6	5	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Frank Takkinen Lake Street	Lake Street	Buy Upgrades $3.5 → $6	Buy	Upgrades	$3.5 → $6	+53.45%	May 15, 2026
Josh Jennings TD Cowen	TD Cowen	Buy Reiterates $5.5	Buy	Reiterates	$5.5	+40.66%	May 15, 2026
Ryan Zimmerman BTIG	BTIG	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 15, 2026
Carl Byrnes Northland Securities	Northland Securities	Buy Maintains $10	Buy	Maintains	$10	+155.75%	Mar 26, 2026

Financial Forecast

Revenue This Year

82.06M

from 71.61M

14.59%

from 71.61M

Revenue Next Year

105.07M

from 82.06M

28.04%

from 82.06M

EPS This Year

-1.10

from -1.74

EPS Next Year

-0.81

from -1.10

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	33.03M	34.42M	50.14M	64.25M	71.61M	82.06M
Revenue Growth	12.98%	4.23%	45.68%	28.14%	11.45%	14.59%
Gross Profit	26.92M	28.38M	42.36M	55.16M	58.82M	67.68M
Gross Margin	81.52%	82.45%	84.48%	85.85%	82.13%	82.48%
Operating Income	-25.08M	-27.51M	-42.66M	-56.59M	-42.53M	-30.21M
Net Income	-25.14M	-26.67M	-35.38M	-61.85M	-48.59M	-34.99M
EPS	-	-	-	-	-1.74	-1.10
Free Cash Flow	-	-9.31M	-24.56M	-32.64M	-18.33M	-29.86M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	84.3M
Avg	82.1M
Low	79.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	17.7%
Avg	14.6%
Low	11.5%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.10
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-